Janux Therapeutics Inc (JANX)
64.78
+2.35
(+3.76%)
USD |
NASDAQ |
May 03, 16:00
65.60
+0.82
(+1.27%)
Pre-Market: 08:55
Janux Therapeutics Price to Book Value: 9.718 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 9.718 |
May 02, 2024 | 9.366 |
May 01, 2024 | 8.730 |
April 30, 2024 | 8.551 |
April 29, 2024 | 8.413 |
April 26, 2024 | 7.110 |
April 25, 2024 | 7.066 |
April 24, 2024 | 7.233 |
April 23, 2024 | 7.468 |
April 22, 2024 | 7.333 |
April 19, 2024 | 7.305 |
April 18, 2024 | 7.329 |
April 17, 2024 | 7.195 |
April 16, 2024 | 7.584 |
April 15, 2024 | 7.780 |
April 12, 2024 | 7.899 |
April 11, 2024 | 7.501 |
April 10, 2024 | 6.694 |
April 09, 2024 | 6.005 |
April 08, 2024 | 5.795 |
April 05, 2024 | 5.269 |
April 04, 2024 | 5.311 |
April 03, 2024 | 5.452 |
April 02, 2024 | 5.381 |
April 01, 2024 | 5.654 |
Date | Value |
---|---|
March 28, 2024 | 5.648 |
March 27, 2024 | 5.689 |
March 26, 2024 | 5.827 |
March 25, 2024 | 5.780 |
March 22, 2024 | 5.930 |
March 21, 2024 | 5.978 |
March 20, 2024 | 5.870 |
March 19, 2024 | 5.795 |
March 18, 2024 | 5.822 |
March 15, 2024 | 5.918 |
March 14, 2024 | 5.666 |
March 13, 2024 | 5.989 |
March 12, 2024 | 5.825 |
March 11, 2024 | 5.996 |
March 08, 2024 | 5.972 |
March 07, 2024 | 6.092 |
March 06, 2024 | 6.311 |
March 05, 2024 | 6.353 |
March 04, 2024 | 6.260 |
March 01, 2024 | 6.403 |
February 29, 2024 | 6.498 |
February 28, 2024 | 6.259 |
February 27, 2024 | 6.682 |
February 26, 2024 | 2.028 |
February 23, 2024 | 2.108 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7737
Minimum
Nov 09 2023
9.718
Maximum
May 03 2024
2.186
Average
1.774
Median
Price to Book Value Benchmarks
Viking Therapeutics Inc | 9.088 |
Equillium Inc | 2.608 |
Minerva Neurosciences Inc | -- |
Arvinas Inc | 3.386 |
Calidi Biotherapeutics Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 352.68 |
Price | 64.78 |
Earnings Yield | -2.05% |
Market Cap | 3.347B |